Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cushing's disease. A review.

W M Burch

    Archives of Internal Medicine
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Transsphenoidal microsurgery (TPS) offers a high cure rate for Cushing's disease by removing ACTH-secreting adenomas. Postoperative hypoadrenalism is a key indicator of successful surgical outcomes for this pituitary disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reduction of contamination risks during clinical studies with Technegas.

    European journal of nuclear medicine·2001
    Same author

    Use of Technegas as a radiopharmaceutical for the measurement of gastric emptying.

    European journal of nuclear medicine·1999
    Same author

    The physical and chemical nature of technegas.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1997
    Same author

    Physical properties and use of pertechnegas as a ventilation agent.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1997
    Same author

    The transition from technegas to pertechnegas.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
    Same author

    The observation of fullerenes in a Technegas lung ventilation unit.

    Nuclear medicine communications·1994
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Area of Science:

    • Endocrinology
    • Neurosurgery
    • Oncology

    Background:

    • Cushing's syndrome presents diagnostic challenges for clinicians.
    • Pituitary-dependent adrenal hyperplasia, or Cushing's disease, requires careful management.
    • Recent experiences at Duke University provide insights into Cushing's disease.

    Purpose of the Study:

    • To review the pathophysiology, etiology, and management of Cushing's disease.
    • To present recent experiences with Cushing's disease at Duke University.
    • To evaluate the role of transsphenoidal microsurgery in treating Cushing's disease.

    Main Methods:

    • Review of recent clinical experiences with Cushing's disease.
    • Analysis of outcomes following transsphenoidal microsurgery (TPS).

    Related Experiment Videos

  • Evaluation of postoperative hypoadrenalism as a marker of cure.
  • Main Results:

    • Transsphenoidal microsurgery (TPS) provides selective adenoma removal and immediate cure of hypercortisolism.
    • TPS preserves pituitary function with minimal morbidity.
    • Postoperative hypoadrenalism is a reliable indicator of surgical success.

    Conclusions:

    • Transsphenoidal surgery has significantly advanced the understanding and treatment of Cushing's disease.
    • While TPS is highly effective, radiotherapy, adrenalectomy, and drug therapy remain options for treatment failures or recurrences.
    • Continued research is needed to optimize management strategies for Cushing's disease.